✦ LIBER ✦

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials

✍ Scribed by Julie E Ledgerwood; Chih-Jen Wei; Zonghui Hu; Ingelise J Gordon; Mary E Enama; Cynthia S Hendel; Patrick M McTamney; Melissa B Pearce; Hadi M Yassine; Jeffrey C Boyington; Robert Bailer; Terrence M Tumpey; Richard A Koup; John R Mascola; Gary J Nabel; Barney S Graham

Book ID: 117791909
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 268 KB
Volume: 11
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(11)70240-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of the recombi

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

✍ Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB

DNA vaccination protects against an infl

DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial

✍ Suzanne Jones; Kirsten Evans; Hilary McElwaine-Johnn; Michaela Sharpe; John Oxfo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 817 KB

Phase 1 clinical trials of the safety an

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

✍ Larry R. Smith; Mary K. Wloch; Ming Ye; Luane R. Reyes; Souphaphone Boutsaboualo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Safety and immunogenicity of a quadrival

Safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-DT): Amulticenter, open-label, non-randomized, phase III clinical trial

✍ Yadav, Sangeeta; Manglani, M. V.; Ashwath Narayan, D. H.; Sharma, S.; Ravish, H. 📂 Article 📅 2014 🏛 Indian Academy of Pediatrics 🌐 English ⚖ 483 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

✍ Jean-Louis Bresson; Christian Perronne; Odile Launay; Catherine Gerdil; Melanie 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 123 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

✍ Jiangtao Lin; Jiansan Zhang; Xiaoping Dong; Hanhua Fang; Jiangting Chen; Nan Su; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 135 KB